Interreg VI news





Innovation in medical imaging value chains

The goals of the InMediValue project are:

– the successful development of a pain-reduced 3D mammography examination procedure to achieve a higher quality and participation rate in breast cancer screening
– the successful development of artificial intelligence-based technology for 3D mammography image analysis to improve the analysis of calcium deposition patterns in radiological reporting
– the successful development of a imaging marker to enable surgeons to localize involved lymph nodes or tumors using innovative imaging techniques.

Demandoriented, practical problems from the field of medical imaging, e.g. from the university hospital as a user were addressed in order to develop solutions in cooperation with the universities and the companies involved. The participating research institutions and companies develop and protect innovative solutions and findings in order to be able to offer them in the short, medium and long term for the benefit of patients. In addition, the products of the participating companies currently being developed are to be brought to market maturity and made accessible across borders for the performance and evaluation of mammography examinations.

The project partners have already achieved very good cross-border successes in the consortium, which cooperates excellently, and are convinced that the ambitious goals of the InMediValue project will be achieved by the end of the project.


Planned project costs

3.437.839,94 €

Project Duration

1.10.2018 - 31.5.2022


Increase of cross-border innovation in the programme area

Lead Partner

Fachhochschule Münster

Project partners

TAFH Münster GmbH, Cysal GmbH, Sigmascreening BV, ScreenPoint Medical BV, MIRA-Institut, Universität Twente, Institut für Klinische Radiologie, Holland Innovative,


Financer Amount
Institut für Klinische Radiologie 94.463,00 €
TAFH Münster GmbH 0,00 €
Provincie Overijssel 81.311,60 €
Fachhochschule Münster 264.088,54 €
EFRE / EFRO 1.718.919,00 €
Ministerie van Economische Zaken en Klimaat 182.951,00 €
Cysal GmbH 58.399,00 €
MIRA-Institut, Universität Twente 59.540,00 €
ScreenPoint Medical BV 304.144,00 €
Sigmascreening BV 154.020,79 €
Provincie Gelderland 40.655,80 €
Holland Innovative 174.429,21 €
MWIDE NRW 304.918,00 €